The goal of this project remains to elucidate the complex mechanisms which
constitute the tissue response to photodynamic therapy (PDT). We have made
the novel observation that PDT alters the expression of IL-6 and IL-10
message and protein in treated tissues in vivo; thus we focus this renewal
application on the mechanisms and consequences of these effects. The
overall hypothesis are that PDT, via its oxidative stress mechanisms,
affects the transcriptional regulation of certain cytokines in vitro and
in vivo, that these effects differ for different photosensitizers,
depending on intracellular localizations, and that these changes in
cytokine expression affect host immune function at both the local and
systemic level. In Specific Aim 1 we will determine:(a) Whether PDT
induced alterations in cytokine gene expression depend on photosensitizer
type and localization. We expect to find photosensitizer (localization)-
dependent differences in the cytokine response similar to those described
for the PDT response of certain early response genes. (b) Whether PDT
affects IL-10 gene regulation directly and what molecular mechanisms are
involved. Based on our in vivo findings of IL-10 upregulation we expect to
find IL-10 gene regulation to be directly affected by PDT in at least some
of the cell types proposed for study. Since very little is known about IL-
10 gene regulation, this study will contribute to an overall understanding
of IL-10 gene control as well as to specific understanding of the effects
of PDT. In Specific Aim II we will determine whether the observed changes
in cytokine expression influence the local or systemic host immune
response, in particular the PDT-induced anti-tumor response and the PDT-
suppressed contact hypersensitivity (CHS) response. We will determine (a)
which cell types (especially in tumor and skin) secrete the cytokines of
interest following PDT in vivo; (b) the effect of PDT on immune cell
function at the tissue level, including antigen presentation and cytotoxic
and cytolytic immunogenicity; (d) and whether changes in cytokine
expression, especially IL-6 and IL-10, are involved in changes in immune
cell function. Since both IL-6 and IL-10 are important in anti-tumor and
CHS responses, it is expected that PDT induced changes in these cytokines
will affect the immune response in vivo. In Specific Aim III we will
determine whether the PDT induced changes in cytokine expression and
changes in inflammatory and immune cell infiltrates observed preclinically
also occur in patients. These studies have the long term goal of improving
the overall understanding of the effect of PDT on the immune system.
No Sub Projects information available for 2P01CA055791-06 0002
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2P01CA055791-06 0002
Patents
No Patents information available for 2P01CA055791-06 0002
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2P01CA055791-06 0002
Clinical Studies
No Clinical Studies information available for 2P01CA055791-06 0002
News and More
Related News Releases
No news release information available for 2P01CA055791-06 0002
History
No Historical information available for 2P01CA055791-06 0002
Similar Projects
No Similar Projects information available for 2P01CA055791-06 0002